Asset Allocation

As of December 31, 2025.
Type % Net
Cash 1.00%
Stock 58.32%
Bond 32.15%
Convertible 0.00%
Preferred 8.04%
Other 0.49%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 93.12%
Mid 4.81%
Small 2.07%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.60%    % Emerging Markets: 0.17%    % Unidentified Markets: 1.23%

Americas 97.05%
96.65%
Canada 85.16%
United States 11.49%
0.40%
Mexico 0.00%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.49%
United Kingdom 0.59%
0.90%
Denmark 0.01%
France 0.14%
Ireland 0.57%
Netherlands 0.00%
Spain 0.11%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.23%
Japan 0.01%
0.21%
Australia 0.21%
0.01%
Singapore 0.01%
0.00%
Unidentified Region 1.23%

Bond Credit Quality Exposure

AAA 27.17%
AA 11.52%
A 18.05%
BBB 21.16%
BB 6.40%
B 1.95%
Below B 0.17%
    CCC 0.17%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.30%
Not Available 13.28%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
60.71%
Materials
1.62%
Consumer Discretionary
4.15%
Financials
53.93%
Real Estate
1.01%
Sensitive
29.42%
Communication Services
1.98%
Energy
11.73%
Industrials
13.11%
Information Technology
2.61%
Defensive
8.80%
Consumer Staples
3.78%
Health Care
0.28%
Utilities
4.75%
Not Classified
1.07%
Non Classified Equity
0.29%
Not Classified - Non Equity
0.78%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 28.37%
Corporate 43.17%
Securitized 0.26%
Municipal 17.23%
Other 10.97%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.80%
Less than 1 Year
0.80%
Intermediate
68.25%
1 to 3 Years
5.73%
3 to 5 Years
14.02%
5 to 10 Years
48.51%
Long Term
30.56%
10 to 20 Years
7.59%
20 to 30 Years
15.42%
Over 30 Years
7.55%
Other
0.39%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial